US 10214529
Small molecules for the treatment of primary cancer and cancer metastasis
granted A61KA61K31/522A61P
Quick answer
US patent 10214529 (Small molecules for the treatment of primary cancer and cancer metastasis) held by The Board of Regents of the University of Texas System expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/522, A61P, A61P35/00